These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Alexianu ME; Kozovska M; Appel SH Neurology; 2001 Oct; 57(7):1282-9. PubMed ID: 11591849 [TBL] [Abstract][Full Text] [Related]
3. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
5. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. Nguyen MD; D'Aigle T; Gowing G; Julien JP; Rivest S J Neurosci; 2004 Feb; 24(6):1340-9. PubMed ID: 14960605 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Manfredi G; Xu Z Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975 [TBL] [Abstract][Full Text] [Related]
8. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224 [TBL] [Abstract][Full Text] [Related]
9. Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration. Li J; Li T; Zhang X; Tang Y; Yang J; Le W Neurobiol Aging; 2014 Apr; 35(4):837-46. PubMed ID: 24126158 [TBL] [Abstract][Full Text] [Related]
10. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model. Matsumoto T; Imagama S; Hirano K; Ohgomori T; Natori T; Kobayashi K; Muramoto A; Ishiguro N; Kadomatsu K Neurosci Lett; 2012 Jun; 520(1):115-20. PubMed ID: 22634473 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Kadoyama K; Funakoshi H; Ohya W; Nakamura T Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Angelov DN; Waibel S; Guntinas-Lichius O; Lenzen M; Neiss WF; Tomov TL; Yoles E; Kipnis J; Schori H; Reuter A; Ludolph A; Schwartz M Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4790-5. PubMed ID: 12668759 [TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799 [TBL] [Abstract][Full Text] [Related]
14. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702 [TBL] [Abstract][Full Text] [Related]
15. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice. Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581 [TBL] [Abstract][Full Text] [Related]
16. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis. Schütz B Neurobiol Dis; 2005 Oct; 20(1):131-40. PubMed ID: 16137574 [TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Kato S Acta Neuropathol; 2008 Jan; 115(1):97-114. PubMed ID: 18026741 [TBL] [Abstract][Full Text] [Related]
18. Microglia in amyotrophic lateral sclerosis. Dewil M; Van Den Bosch L; Robberecht W Acta Neurol Belg; 2007 Sep; 107(3):63-70. PubMed ID: 18072333 [TBL] [Abstract][Full Text] [Related]
19. Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis. Sanagi T; Yuasa S; Nakamura Y; Suzuki E; Aoki M; Warita H; Itoyama Y; Uchino S; Kohsaka S; Ohsawa K J Neurosci Res; 2010 Sep; 88(12):2736-46. PubMed ID: 20648658 [TBL] [Abstract][Full Text] [Related]
20. Impaired recruitment of neuroprotective microglia and T cells during acute neuronal injury coincides with increased neuronal vulnerability in an amyotrophic lateral sclerosis model. Kawamura MF; Yamasaki R; Kawamura N; Tateishi T; Nagara Y; Matsushita T; Ohyagi Y; Kira J Exp Neurol; 2012 Apr; 234(2):437-45. PubMed ID: 22293437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]